Announcement of a US subsidiary of a Japanese life insurance company
Jan 22, 2018
byInvestment in Japan
What's Happened in Japan
・Protective to Acquire In Force Blocks of Individual Life and Annuity Business.
・Otsuka Pharmaceutical, a Japanese pharmaceutical company, received approval in Japan for the manufacture and sale of new antipsychotic drug Rexulti® Tablets for schizophrenia.
Jump to The Corporate Announcement Page from Following